Watermark
  Back to Search Results

BGB-11417-301

Active, not recruiting

Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Participants With Chronic Lymphocytic Leukemia (CLL)

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-11417-301

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT06073821

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20241195

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents